These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 20683389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analytical toxicology of emerging drugs of abuse--an update.
    Meyer MR, Peters FT.
    Ther Drug Monit; 2012 Dec; 34(6):615-21. PubMed ID: 23131695
    [Abstract] [Full Text] [Related]

  • 6. Piperazine compounds as drugs of abuse.
    Arbo MD, Bastos ML, Carmo HF.
    Drug Alcohol Depend; 2012 May 01; 122(3):174-85. PubMed ID: 22071119
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [New designer drugs. Pharmacology, toxicology and metabolism].
    Staack RF, Springer D, Theobald DS, Maurer HH.
    Med Monatsschr Pharm; 2004 Dec 01; 27(12):408-13. PubMed ID: 15646689
    [No Abstract] [Full Text] [Related]

  • 9. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
    Loeffler G, Hurst D, Penn A, Yung K.
    Mil Med; 2012 Sep 01; 177(9):1041-8. PubMed ID: 23025133
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Re: "Spice, bath salts, and the U.S. Military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces".
    Platteborze PL, Martin TM.
    Mil Med; 2013 Jan 01; 178(1):v. PubMed ID: 23356108
    [No Abstract] [Full Text] [Related]

  • 12. Emerging trends in the abuse of designer drugs and their catastrophic health effects: update on chemistry, pharmacology, toxicology and addiction potential.
    Rapaka RS, Purohit V, Schnur P, Rutter J.
    Life Sci; 2014 Feb 27; 97(1):1. PubMed ID: 24529194
    [No Abstract] [Full Text] [Related]

  • 13. Toxicology and management of novel psychoactive drugs.
    Kersten BP, McLaughlin ME.
    J Pharm Pract; 2015 Feb 27; 28(1):50-65. PubMed ID: 25261428
    [Abstract] [Full Text] [Related]

  • 14. Bath salts and other emerging toxins.
    Thornton MD, Baum CR.
    Pediatr Emerg Care; 2014 Jan 27; 30(1):47-52; quiz 53-5. PubMed ID: 24378862
    [Abstract] [Full Text] [Related]

  • 15. Novel psychoactive substances.
    Krabseth HM, Tuv SS, Strand MC, Karinen RA, Wiik E, Vevelstad MS, Westin AA, Øiestad EL, Vindenes V.
    Tidsskr Nor Laegeforen; 2016 May 27; 136(8):714-7. PubMed ID: 27143461
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of designer drugs of abuse.
    Staack RF, Maurer HH.
    Curr Drug Metab; 2005 Jun 27; 6(3):259-74. PubMed ID: 15975043
    [Abstract] [Full Text] [Related]

  • 17. Kratom alkaloids and O-desmethyltramadol in urine of a "Krypton" herbal mixture consumer.
    Arndt T, Claussen U, Güssregen B, Schröfel S, Stürzer B, Werle A, Wolf G.
    Forensic Sci Int; 2011 May 20; 208(1-3):47-52. PubMed ID: 21112167
    [Abstract] [Full Text] [Related]

  • 18. Doors of deception: the diaspora of designer drugs.
    Kerwin J.
    Drug Test Anal; 2011 Sep 20; 3(9):527-31. PubMed ID: 21960538
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of a new drug of abuse: cathinone derivative 1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-one.
    Weiß JA, Taschwer M, Kunert O, Schmid MG.
    J Sep Sci; 2015 Mar 20; 38(5):825-8. PubMed ID: 25545103
    [Abstract] [Full Text] [Related]

  • 20. Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives.
    Kraemer T, Maurer HH.
    Ther Drug Monit; 2002 Apr 20; 24(2):277-89. PubMed ID: 11897973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.